Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

Authors: Muthiah Vaduganathan, Orly Vardeny, Thomas Michel, John J.V. McMurray, Marc A. Pfeffer, Scott D. Solomon - New England Journal of Medicine, NEJM 2020 cited by 2,171

RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hy...